Abstract:Classical swine fever virus (CSFV) is the etiological agent of classical swine fever, a highly contagious dis-ease that causes significant economic losses to the swine industry. Systemic prophylactic immunization with the live attenuated vaccine, the C-strain vaccine, is one of the effective measures for CSF control. However, one of the limitations of the C-strain vaccine is that the field strains-infected animals cannot be differentiated from the C-strain vaccinated herds by serological tests (DIVA). This constraint hampers the practical usage of the C-strain vaccine to eradicate the CSF in China. In the current study, a novel CSF modified live marker vaccine candidate was constructed based on the attenuation of the prevalent 2.1 genotype strain by the deletion of two virulence associated functional residues in the CSFV Erns, H79, and C171. Meanwhile, four residues S14, G22, E24, and E25 were identified specifically for the 6B8 mAb binding to the CSFV E2 as the novel conformational epitope. Then four substitutions of S14K, G22A, E24R, and G25D were further incorporated in the double deletion construct as a negative serolog-ical marker. Finally, the double-deletion marker MLV candidate GD18-ddErnHC-KARD was rescued, and its safety and efficacy profiles were evaluated in piglets. The safety study results indicated that the can-didate did not induce fever, clinical signs, or pathological lesions with a high dose of 105.0 TCID50, and in addition, no virus shedding was detected until 21 days post-inoculation. Meanwhile, the efficacy study results demonstrated that at a low dose of 103.0 TCID50, it conferred complete clinical protection and no virus shedding was detected after the challenge with a highly virulent Shimen strain. Importantly, the infected animals were differentiated using the accompanied DIVA ELISA. These results constitute a proof-of-concept for rationally designing a CSF antigenically marked modified live vaccine candidate.(c) 2022 Elsevier Ltd. All rights reserved.

Progress on Molecular Biology and Diagnostic Technique of Classical Swine Fever Virus

A Review Of Molecular Characterization Of Classical Swine Fever Virus (Csfv)

Progress on technology for detection classical swine fever

Recent Advances in the Diagnosis of Classical Swine Fever and Future Perspectives

Studies on Biological Characteristics of Classical Swine Fever Virus

Classical Swine Fever in China-An Update Minireview

COMPARISON AND APPLICATION OF SYBR GREEN AND TAQMAN BASED REAL-TIME PCR ASSAYS FOR DETECTION OF CLASSICAL SWINE FEVER VIRUS

Research Status of CSF Marker Vaccine

New ideas and Key Technologies of Prevention and Control for Classical Swine Fever

Research Progress and Challenges in Vaccine Development Against Classical Swine Fever Virus

Anti-Classical Swine Fever Virus Strategies

Summary of domestic and foreign epidemic situation on classical swine fever

The Development of Classical Swine Fever Marker Vaccines in Recent Years

Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate

Current detection methods of African swine fever virus

Analysis tissue tropism of classical swine fever virus using SYBR real time PCR

Studies on Cytokine mRNA expressions in the PBMC of CSFV-Infected pigs

Advances in the diagnostic techniques of African swine fever

Establishment and Preliminary Application of Real-time PCR Assay for Quantitative Detection of Classical Swine Fever Virus

Epidemiology, diagnosis and control of classical swine fever: Recent developments and future challenges

Diagnosis of Mixed Infection of Classical Swine Fever Virus(CSFV)and Porcine Reproductive and Respiratory Syndrome Virus(PRRSV)